Yakira Capital Management’s PTK Acquisition Corp. Warrants, each whole warrant exercisable for one half (1/2) of a share of Comm PTK.WS Stock Holding History

Yakira Capital Management’s Portfolio PTK.WS Stock Details PTK.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100,000	Closed	-$52K	–	437
2021 Q2	$52K	Buy	+100,000	New	+$59.5K	0.01%	352

Other funds holding PTK.WS

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Yakira Capital Management's PTK.WS Position: Q3 2021 in Review

Yakira Capital Management sold out of PTK Acquisition Corp. Warrants, each whole warrant exercisable for one half (1/2) of a share of Comm (PTK.WS) in Q3 2021, closing a stake of 100,000 shares — an estimated $52K sold.

Yakira Capital Management first reported a position in PTK.WS in Q2 2021 and held it in 1 quarter. The position peaked at $52K in Q2 2021. 2 funds tracked by Wall St. Rank hold PTK.WS as of Q3 2021.

Yakira Capital Management reported no remaining PTK Acquisition Corp. Warrants, each whole warrant exercisable for one half (1/2) of a share of Comm position as of Q3 2021 after selling out during the quarter.
Yakira Capital Management sold 100,000 PTK Acquisition Corp. Warrants, each whole warrant exercisable for one half (1/2) of a share of Comm shares in Q3 2021, an estimated $52K.
Yakira Capital Management first reported a position in PTK Acquisition Corp. Warrants, each whole warrant exercisable for one half (1/2) of a share of Comm in Q2 2021 and held it in 1 quarter.
Yakira Capital Management's PTK Acquisition Corp. Warrants, each whole warrant exercisable for one half (1/2) of a share of Comm position peaked at $52K in Q2 2021.
2 funds tracked by Wall St. Rank held PTK Acquisition Corp. Warrants, each whole warrant exercisable for one half (1/2) of a share of Comm as of Q3 2021.

Based on Yakira Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.